Cited by — Targeting H3K27-Altered Diffuse Midline Glioma with Combined MEK and HDAC Inhibition: Clinical Response and in Vitro Validation | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Targeting H3K27-Altered Diffuse Midline Glioma with Combined MEK and HDAC Inhibition: Clinical Response and in Vitro Validation.
No admitted local citation edges point to this work yet.
